🔎 Trials Near Me

Utama › Kanser Payudara › Louisiana › New Orleans

Kajian klinikal Kanser Payudara di New Orleans, LA

11 kajian untuk Kanser Payudara sedang mencari peserta di lokasi dalam dan sekitar New Orleans (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • University Medical Center New Orleans, New Orleans
  • Touro Infirmary, New Orleans
  • West Jefferson Medical Center, Marrero · 4 mi jauh
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Mengambil pesertaFasa 3
  • Ochsner Clinic Foundation ( Site 0021), New Orleans
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06966700

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Mengambil pesertaFasa 3
  • University Medical Center-New Orleans, New Orleans
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06492616

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

Mengambil pesertaFasa 1
  • Ochsner Medical Center (OMC), New Orleans
Umur 18 hingga 55 · Wanita · Dikemas kini 9 Sep 2026 · NCT07310420

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Mengambil pesertaFasa 3
  • Care Access-Marrero, Marrero · 4 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06072612

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Mengambil pesertaFasa 3
  • Louisiana State University Health Science Center, New Orleans
  • University Medical Center New Orleans, New Orleans
  • Touro Infirmary, New Orleans
  • dan 1 lagi
Umur 18 hingga 60 · Wanita · Dikemas kini 2 Sep 2026 · NCT05879926

E-Mindfulness Approaches for Living After Breast Cancer

Mengambil pesertaFasa 3
  • University Medical Center New Orleans, New Orleans
Umur 18 hingga 50 · Semua jantina · Dikemas kini 4 Ogo 2026 · NCT06748222

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • Louisiana State University Health Sciences Center, New Orleans
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jul 2026 · NCT05768139

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Mengambil pesertaFasa 3
  • Louisiana State University Health Science Center, New Orleans
  • University Medical Center New Orleans, New Orleans
  • Ochsner Medical Center Jefferson, New Orleans
Umur 50 hingga 70 · Semua jantina · Dikemas kini 23 Apr 2026 · NCT04852887

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Mengambil pesertaKajian pemerhatian
  • Massive Bio SYNERGY-AI site, New Orleans
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

CtDNA Based MRD Testing for NAC Monitoring in TNBC

Mengambil pesertaKajian pemerhatian
  • Louisiana State University, New Orleans
Umur 18 ke atas · Wanita · Dikemas kini 7 Jan 2025 · NCT06230185

Kajian Kanser Payudara di bandar lain

Kajian lain di New Orleans

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.